Somaxon, Actavis neurology news

Somaxon granted Actavis non-exclusive rights to sell a generic version of insomnia drug Silenor doxepin to settle litigation between the two companies. Actavis will have rights beginning January 1, 2020, or earlier

Read the full 325 word article

How to gain access

Continue reading with a
two-week free trial.